![]() |

![]() |
Dr. Hahm joined NGOC in 2000 following completion of her fellowship and an additional year of research at Johns Hopkins University. She is Board Certified in Internal Medicine and Medical Oncology and sees patients at the Marietta and Cartersville clinics. Dr. Hahm enjoys research and clinical trials. Although she has a special interest in the treatment of breast cancer, Dr. Hahm is committed to care for patients with all tumor types. |
| HILLARY A. HAHM, M.D., Ph.D. | |
| OFFICE ADDRESS | NORTHWEST GEORGIA ONCOLOGY CENTERS, P.C. MARIETTA CENTER 340 Kennestone Hospital Blvd., Suite 200 Marietta, GA 30060 Phone: (770) 281-5100 Fax: (678) 581-7100 |
| PERSONAL DATA | Birthplace: West Islip, NY |
| UNDERGRADUATE EDUCATION | BS in Pharmacy, 1981 State University of New York at Buffalo, NY |
| MEDICAL EDUCATION | PhD, Pharmacology, 1989 State University of New York at Buffalo, NY Doctor of Medicine, 1992 Johns Hopkins University Baltimore, MD |
| POSTDOCTORAL TRAINING | INTERNSHIP AND RESIDENCY Internal Medicine Johns Hopkins University, University Hospital Baltimore, MD July 1992 June 1995 FELLOWSHIP Medical Oncology Johns Hopkins University, University Hospital Baltimore, MD July 1995 June 1999 |
| BOARD CERTIFICATION | American Board of Internal Medicine, Internal Medicine 1995, 2005 American Board of Internal Medicine, Medical Oncology 1997 |
| MEDICAL LICENSURE | State of Georgia (Active) |
| PROFESSIONAL SOCIETIES | American Society of Clinical Oncology, 1997 Present Georgia Society of Clinical Oncology, 2000 Present Cobb County Medical Society, 2000 Present |
| HONORS |
Pharmacy Scholarship, State University of NY, 1979 |
| PUBLICATIONS | ARTICLES: H.A.Hahm, D.S. Ettinger, K.Bowling, B. Hoker, T.L. Chen, Y. Zabelina, and R.A. Casero Jr “Phase I Study of N1-N11-Diethylnorspermine (DENSPM) in Patients with Non-Small Cell Lung Cancer (NSCLC).” In Clinical Cancer Research, Vol 8, 684-690, 2002. H.A. Hahm, V.R. Dunn, K.A. Butash, W.L Deveraux, P.M. Woster, R.A. Casero Jr, N.E. Davidson “Combination of Standard Cytotoxic Agents with Polyamine Analogues in the Treatment of Breast Cancer Cell Lines.” In Clinical Cancer Research Vol 7, 391-399, 2001. H.A. Hahm, D.K. Armstrong, T.L. Chen, L. Grochow, J. Passos-Coelho, S.N. Goodman, N.E. Davidson, and M.J. Kennedy, "Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer." In Biology of Blood and Marrow Transplantation Vol. 6(3A), 335-343, 2000. H.A. Hahm, V.R. Dunn, K.A. Butash, W.L Deveraux, P.M. Woster, R.A. Casero Jr, N.E. Davidson "Combination of Standard Cytotoxic Agents with Polyamine Analogues in the Treatment of Breast Cancer Cell Lines." In Clinical Cancer Research Vol 7, 391-399, 2001. H.A.Hahm, D.S. Ettinger, K.Bowling, B. Hoker, T.L. Chen, Y. Zabelina, and R.A. Casero Jr "Phase I Study of N1-N11-Diethylnorspermine (DENSPM) in Patients with Non-Small Cell Lung Cancer (NSCLC)." In Clinical Cancer Research, in press, 2002. G.A. White, H.A. Hahm, and C. Ip, "Selenoprotein Expression in Three Rat Mammary Tumor Cell Lines with Different Sensitivity to Selenium Inhibition of Growth.", in Proceedings of AACR, Vol 28, Abstract 222, 1987. H.A. Hahm and M.M. Ip, "Growth and Development of Normal Rat Mammary Epithelium within a Basement Membrane Matrix.", in Proceedings of AACR, Vol 28, Abstract 117, 1987. |
| MAJOR RESEARCH INTERESTS |
Clinical Trials (Oncology & Hematology) For a listing of the Active Clinical Trials that NGOC participates in, click here Use your browser's "back" button to return to this physician's page |
NEWS, EVENTS & ACTIVITIES | WILLIAM S. GIBBONS CANCER RESEARCH INSTITUTE | SEARCH-THE-SITE |
|